[1]Patent:WO2004/46141,2004,A1.Locationinpatent:Page57
[1]Chemistry-AEuropeanJournal,2021,vol.27,p.2868-2874
[1]Cheng,Bao;Zhu,Guirong;Meng,Linghua;Wu,Guolin;Chen,Qin;Ma,Shengming[EuropeanJournalofMedicinalChemistry,2022,vol.228]
135-00-2
56662-33-0
31161-46-3
118150-25-7
31161-47-4
56824-70-5
32998-26-8 | 2-chloro-3-(1-piperidyl)quinoxaline | AA00CRQF | MFCD00105617
34579-77-6 | 2,2-DIETHYL-BUTYRONITRILE | AA00CU2J | MFCD16698288
361395-33-7 | 4,5,6,7-Tetrahydro-1H-benzo[d]imidazole-7-carboxylic acid | AA00CWE5 | MFCD23135595
314763-97-8 | 3-Iodo-4-methoxybenzohydrazide | AA00CYSY | MFCD02025091
31995-60-5 | 5-Methyl-4-nitro-1H-benzo[d][1,2,3]triazole | AA00D0FX | MFCD00962617
35856-61-2 | Ethyl(methyl)sulfamoyl chloride | AA00D2G9 | MFCD11622866
331713-77-0 | N-(2-Methoxybenzyl)-3-oxobutanamide | AA00D4GX | MFCD00844470
380436-98-6 | 3-(2,5-DiMethoxyphenyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one | AA00D5MB | MFCD01933667
42448-56-6 | PENTAMETHYLBENZENETHIOL | AA00D74V | MFCD06655221
5608-24-2 | PRIMA-1 | AA00D7WG | MFCD04974196